Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |